13 employees
Profectus Biosciences is a R&D company developing vaccine and small molecules to treat and prevent viral diseases and cancers.
2005
$7.3M
from 2 investors over 2 rounds
Profectus BioSciences, Inc raised $7.3M on April 18, 2014
Investors: Cross Atlantic Capital Partners
Profectus BioSciences, Inc raised $3M on June 15, 2007